|

[64Cu]Cu-AKY-2519 (imaging) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Aktis Oncology, Inc.1

Indications

  • B7H31
  • Castration Resistant Metastatic Prostate Cancer1
  • mCRPC1
  • mCRPC (Metastatic Castration-resistant Prostate Cancer)1
  • Prostate Cancer1

Miami, Florida1 trial

A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer

Biogenix Molecular, LLC

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.